Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
MC vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Diversified
MC vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $4.68B | $849.03B |
| Revenue (TTM) | $1.52B | $270.79B |
| Net Income (TTM) | $233M | $58.03B |
| Gross Margin | 99.2% | 58.6% |
| Operating Margin | 18.1% | 27.7% |
| Forward P/E | 20.8x | 14.2x |
| Total Debt | $267M | $751.15B |
| Cash & Equiv. | $509M | $469.32B |
MC vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Moelis & Company (MC) | 100 | 189.7 | +89.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 323.6 | +223.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MC vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MC is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 27.0%, EPS growth 65.2%
- Lower volatility, beta 1.75, Low D/E 39.3%, current ratio 21.47x
- Beta 1.75, yield 4.1%, current ratio 21.47x
JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 14 yrs, beta 1.00, yield 1.6%
- 471.7% 10Y total return vs MC's 261.3%
- Lower P/E (14.2x vs 20.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.0% NII/revenue growth vs JPM's 14.6% | |
| Value | Lower P/E (14.2x vs 20.8x) | |
| Quality / Margins | Efficiency ratio 0.3% vs MC's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 1.00 vs MC's 1.75 | |
| Dividends | 4.1% yield, 1-year raise streak, vs JPM's 1.6% | |
| Momentum (1Y) | +28.7% vs MC's +25.4% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs MC's 0.8% |
MC vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MC vs JPM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $270.8B annually — 178.5x MC's $1.5B. JPM is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to MC's 15.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $270.8B |
| EBITDAEarnings before interest/tax | $286M | $81.3B |
| Net IncomeAfter-tax profit | $233M | $58.0B |
| Free Cash FlowCash after capex | $540M | -$119.7B |
| Gross MarginGross profit ÷ Revenue | +99.2% | +58.6% |
| Operating MarginEBIT ÷ Revenue | +18.1% | +27.7% |
| Net MarginNet income ÷ Revenue | +15.4% | +21.6% |
| FCF MarginFCF ÷ Revenue | +35.6% | -15.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -4.3% | +16.0% |
Valuation Metrics
JPM leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 15.9x trailing earnings, JPM trades at a 27% valuation discount to MC's 21.7x P/E. On an enterprise value basis, JPM's 13.6x EV/EBITDA is more attractive than MC's 15.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.7B | $849.0B |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $1.13T |
| Trailing P/EPrice ÷ TTM EPS | 21.70x | 15.94x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | 14.17x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.23x |
| EV / EBITDAEnterprise value multiple | 15.55x | 13.62x |
| Price / SalesMarket cap ÷ Revenue | 3.09x | 3.14x |
| Price / BookPrice ÷ Book value/share | 7.43x | 2.63x |
| Price / FCFMarket cap ÷ FCF | 8.68x | — |
Profitability & Efficiency
MC leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
MC delivers a 37.9% return on equity — every $100 of shareholder capital generates $38 in annual profit, vs $16 for JPM. MC carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.18x. On the Piotroski fundamental quality scale (0–9), MC scores 6/9 vs JPM's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +37.9% | +16.1% |
| ROA (TTM)Return on assets | +15.9% | +1.3% |
| ROICReturn on invested capital | +24.9% | +5.4% |
| ROCEReturn on capital employed | +22.0% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.39x | 2.18x |
| Net DebtTotal debt minus cash | -$241M | $281.8B |
| Cash & Equiv.Liquid assets | $509M | $469.3B |
| Total DebtShort + long-term debt | $267M | $751.1B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,034 today (with dividends reinvested), compared to $14,435 for MC. Over the past 12 months, JPM leads with a +28.7% total return vs MC's +25.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 34.0% vs MC's 26.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.5% | -2.3% |
| 1-Year ReturnPast 12 months | +25.4% | +28.7% |
| 3-Year ReturnCumulative with dividends | +103.7% | +140.8% |
| 5-Year ReturnCumulative with dividends | +44.3% | +110.3% |
| 10-Year ReturnCumulative with dividends | +261.3% | +471.7% |
| CAGR (3Y)Annualised 3-year return | +26.8% | +34.0% |
Risk & Volatility
JPM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
JPM is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than MC's 1.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 93.4% from its 52-week high vs MC's 81.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.75x | 1.00x |
| 52-Week HighHighest price in past year | $78.22 | $337.25 |
| 52-Week LowLowest price in past year | $51.06 | $248.83 |
| % of 52W HighCurrent price vs 52-week peak | +81.6% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 48.1 | 53.4 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 8.4M |
Analyst Outlook
Evenly matched — MC and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates MC as "Hold" and JPM as "Buy". Consensus price targets imply 15.1% upside for MC (target: $73) vs 7.6% for JPM (target: $339). For income investors, MC offers the higher dividend yield at 4.13% vs JPM's 1.63%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $73.40 | $338.78 |
| # AnalystsCovering analysts | 22 | 61 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +1.6% |
| Dividend StreakConsecutive years of raises | 1 | 14 |
| Dividend / ShareAnnual DPS | $2.63 | $5.13 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +3.4% |
JPM leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). MC leads in 1 (Profitability & Efficiency). 1 tied.
MC vs JPM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MC or JPM a better buy right now?
For growth investors, Moelis & Company (MC) is the stronger pick with 27.
0% revenue growth year-over-year, versus 14. 6% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 9x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MC or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 9x versus Moelis & Company at 21. 7x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 2x.
03Which is the better long-term investment — MC or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +110. 3%, compared to +44. 3% for Moelis & Company (MC). Over 10 years, the gap is even starker: JPM returned +471. 7% versus MC's +261. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MC or JPM?
By beta (market sensitivity over 5 years), JPMorgan Chase & Co.
(JPM) is the lower-risk stock at 1. 00β versus Moelis & Company's 1. 75β — meaning MC is approximately 74% more volatile than JPM relative to the S&P 500. On balance sheet safety, Moelis & Company (MC) carries a lower debt/equity ratio of 39% versus 2% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — MC or JPM?
By revenue growth (latest reported year), Moelis & Company (MC) is pulling ahead at 27.
0% versus 14. 6% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Moelis & Company grew EPS 65. 2% year-over-year, compared to 21. 7% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MC or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 21. 6% net margin versus 15. 4% for Moelis & Company — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus 18. 1% for MC. At the gross margin level — before operating expenses — MC leads at 99. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MC or JPM more undervalued right now?
On forward earnings alone, JPMorgan Chase & Co.
(JPM) trades at 14. 2x forward P/E versus 20. 8x for Moelis & Company — 6. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MC: 15. 1% to $73. 40.
08Which pays a better dividend — MC or JPM?
All stocks in this comparison pay dividends.
Moelis & Company (MC) offers the highest yield at 4. 1%, versus 1. 6% for JPMorgan Chase & Co. (JPM).
09Is MC or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), 1. 6% yield, +471. 7% 10Y return). Moelis & Company (MC) carries a higher beta of 1. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +471. 7%, MC: +261. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MC and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MC is a small-cap high-growth stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.